Patient info Open main menu

Netilmicin/ Dexamethasone 3 mg/ml + 1 mg/ml eye drops, solution, in single-dose Container – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Not available Details

Medicine strength:
3 mg/ml + 1 mg/ml
Contains active substances:
Similar medicines:

Patient leaflet - Netilmicin/ Dexamethasone 3 mg/ml + 1 mg/ml eye drops, solution, in single-dose Container

1. What Netildex is and what it is used for

Netildex contains two medicines: netilmicin

and dexamethasone.

  • Netilmicin is an antibiotic which kills

    bacteria.

  • Dexamethasone is a steroid that reduces

    inflammation.

Netildex is used in adults to reduce

inflammation and to kill bacteria in eyes that

are swollen, irritated and likely to be infected

by bacteria.

You must talk to a doctor if you do not feel

better or if you feel worse at the end of the

treatment.

2. What you need to know before you use Netildex

Netildex can be used in adults, including the

elderly.

It is not recommended for anyone under 18

years of age.

Do not use Netildex:

  • if you are allergic to netilmicin,

    dexamethasone, antibiotics that are

    known as aminoglycoside antibiotics (such as: tobramycin, kanamicyn, amikacin, gentamicin, etc) or any of the other ingredients of this medicine (listed in section 6).

    • if your doctor has advised you that the pressure in your eye is too high.
    • if you think you may have a viral or fungal infection in or around your eye.
    • if you have now, or have had in the past, a viral infection of the eye caused by the herpes simplex virus (HSV).
    • if your doctor has advised you that you have an infection of the eye caused by the bacterium known as mycobacteria.

Warnings and precautions

Talk to your doctor or pharmacist before using Netildex.

Talk to your doctor if you experience swelling and weight gain around the trunk and in the face as these are usually the first manifestations of a syndrome called Cushing’s syndrome. Suppression of the adrenal gland function may develop after stopping a long-term or intensive treatment with Netildex. Talk to your doctor before stopping the treatment by yourself. These 1G155360P2

Package leaflet: Information for the patient

NetilDEX® 3 mg/ml + 1 mg/ml eye drops, solution in single-dose container

Netilmicin / Dexamethasone

1664

PAG 01

PAG 04

risks are especially important in children and patients treated with a drug called ritonavir or cobicistat.

Contact your doctor if you experience blurred vision or other visual disturbances.

If you use Netildex for a long time

  • the pressure in your eye may increase
  • you may develop cataract;
  • wounds may take longer to heal;
  • your body may not fight other types of

    infections in your eye as well as normal, such as fungal or viral infections;

  • eye infections that produce a lot of

    pus, with the use of corticosteroids, may become worse or it may be more difficult to identify the type of bacteria causing the infection;

  • the steroid in Netildex may cause

    thinning of the surfaces of the eye and even perforations;

  • you may start to become allergic to the

    antibiotic in the eye drops.

Before you use Netildex tell your doctor if you

  • have glaucoma or a family history of

    glaucoma;

  • have problems with your cornea;
  • are taking any other medicines

    containing phosphates. Your doctor will want to check your cornea at regular intervals;

Children and adolescents

Netildex is not recommended for use in children or adolescents (aged from birth to 18 years of age).

For external use only

Only use Netildex on the surface of your eye. This medicine should never be injected or swallowed.

Other medicines and Netildex

Netildex may interact with other medicines. Tell your doctor or pharmacist if you are taking or have recently taken any ophthalmic product or any other medicines, including medicines obtained without a prescription. You can still use Netildex with other ophthalmic products, but follow the instructions in section 3.

In particular, tell your doctor or pharmacist if you are taking:

  • any other antibiotics, in particular

    polymyxin B, colistin, viomycin, streptomycin, vancomycin and cephaloridine. Using other antibiotics at the same time as Netildex may increase the risk of kidney problems, hearing problems or it may affect how well the other antibiotics work;

  • cisplatin, an anti-cancer drug;
  • diuretics (medicines to reduce water

    retention) such as ethacrynic acid and furosemide;

  • anticholinergic medicines (medicines

    that stop glands secreting), such as atropine;

  • ritonavir or cobicistat, as this may

    increase the amount of dexamethasone in the blood;

  • other medicines containing phosphates.

    Your doctor will monitor your cornea at regular intervals.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby ask your doctor or pharmacist for advice before taking this medicine.

Use in pregnancy

It is preferable not to use Netildex during pregnancy unless your doctor considers it is necessary.

Use in breast-feeding

Netildex should not be used if you are breast-feeding.

Driving and using machines

When you use Netildex your vision may become blurred for a short time. If this happens, do not drive or use any tools or machines until your vision becomes clear again.

Netildex contains phosphates

This medicine contains 0.18 mg phosphates in each drop which is equivalent to 3.66 mg/ml. If you suffer from severe damage to the clear layer at the front of the eye (the cornea), phosphates may cause in very rare cases cloudy patches on the cornea due to calcium build-up during treatment.

3. How to use Netildex

Always use this medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

The recommended dose is one drop in the affected eye four times a day or as prescribed. The usual treatment duration

can vary from 5 to 14 days.

Do not change the dose of the eye drops without consulting your doctor.

Use in children and adolescents

Netildex is not recommended for use in children or adolescents (aged from birth to 18 years of age).

Contact lens wearers

Netildex in single-dose containers can be used while you wear contact lenses because it does not contain preservatives. However, it is strongly advised to avoid wearing contact lenses during an eye infection or inflammation. Contact lenses should not be worn during treatment with steroid eye drops due to increased risk of infection. If you use Netildex with other eye drops

Wait at least 10 minutes between using Netildex and using the other eye drops or ointments. Eye ointments should be placed last.

Instructions for use

Make sure the single dose container is intact.

  1. 1.

    Wash your hands and sit or position your

    self comfortably.

  2. 2.

    Open the aluminium sachet containing

    the single-dose containers.

  3. 3.

    Separate the single-dose container

    from the strip (Picture 1) and put the unopened containers back into the sachet

  4. 4.

    Open by twisting the upper part without

    pulling (Picture 2)

    Do not touch the tip after opening the container.

  5. 5. Tilt the head back.
  6. 6.

    Use your finger to gently pull down the

    lower eyelid of your affected eye.

  7. 7.

    Invert the single-dose container and

    place the tip of the container close to, but not touching your eye.

    Do not allow the container tip to touch your eye or eyelid (Picture 3).

  8. 8.

    Squeeze the single-dose container in

    order to administrate only one drop, then release the lower eyelid.

  9. 9.

    Close your eye and press a finger against

    the corner by the nose of the affected eye. Hold for 2 minutes.

  10. 10.

    Repeat in the other eye if your doctor has

    told you to do this.

  11. 11.

    Discard the single dose container after use.

    (Picture 1) (Picture 2) (Picture 3)

    If you use the eye drops incorrectly, it can become contaminated by bacteria which may lead to eye infections. Serious ocular damage and subsequent loss of vision may result from using contaminated eye drops.

    If you use more Netildex than you should

    If you use too many drops it is unlikely to cause problems.

    Apply the next dose as usual.

    If you forget to use Netildex

    Do not use a double dose to make up for a forgotten dose.

    Apply the next dose as usual.

    If you stop using Netildex

    If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The frequency of the individual effect listed cannot be estimated from the available data. Eye disorders

Increased eye pressure, cataract formation after prolonged treatments, blurred vision, developing or worsening of a viral infection of the eye caused by the herpes simplex virus (HSV) or a fungal infection, delayed wound healing.

In very rare cases (less than 1 in every 10,000), some patients with severe damage to the clear layer at the front of the eye (the cornea) have developed cloudy patches on the cornea due to calcium build-up during treatment.

Immune system disorders

Local allergic reaction: redness of the conjunctiva, burning, pruritus.

Hormonal disorders

Growth of extra body hair (particularly in women), muscle weakness and wasting, purple stretch marks on body skin, increased blood pressure, irregular or missing periods, changes in the levels of protein and calcium in your body, stunted growth in children and teenagers and swelling and weight gain of the body and face (called ‘Cushing’s syndrome’) (see section 2, “Warnings and precautions”).

In all the above cases, it is recommended to discontinue treatment.

PAG 03

PAG 02

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/ yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Netildex

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton, sachet and container after EXP. The expiry date refers to the last day of that month.

Store below 30 °C.

Store the single-dose containers in the sachet in order to protect from light and moisture.

This medicine does not contain

preservatives.

After first opening of a single-dose container, use immediately and throw away the single-dose container with any remaining contents after use.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Netildex contains

The active substances are dexamethasone 1 mg/ml (as dexamethasone disodium phosphate) and netilmicin 3 mg/ml (as netilmicin sulphate). Each single dose container contains 0.9 mg of netilmicin and 0.3 mg of dexamethasone.

The other ingredients are:

sodium citrate,

monobasic sodium phosphate

monohydrate,

disodium phosphate dodecahydrate, purified water.

What Netildex looks like and contents of the pack

Netildex is a clear, colourless or slightly yellow solution.

Netildex single dose eye drops:

Five single-dose containers, each containing 0.3 ml of Netildex eye drops, solution wrapped in an aluminium sachet. Each pack contains 15 or 20 single-dose containers.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

SIFI Pharmaceuticals Limited

29/30 Fitzroy Square

London W1T 6LQ

United Kingdom

Manufacturer:

SIFI S.p.A.

Via Ercole Patti 36

95025 Aci S. Antonio (Catania) Italy

Distributed by:

ParaPharm Development Limited, Building 1410

Arlington Business Park

Theale – Reading, RG7 4SA, United Kingdom

This leaflet was last revised in August 2022

Detailed information on this medicine is available on the website of

www.mhra.gov.uk.

Detailed and updated information on this product is available by scanning the QR code included below or on the outer packaging with a smartphone.

The same information is also available at the following URL:

http://qr.sifigroup.com/1g155360/

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLGB 53941/0018

Last revision stated in the text: August 2022 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Netilmicin/ Dexamethasone 3 mg/ml + 1 mg/ml eye drops, solution, in single-dose Container

Active substances Dexamethasone, Netilmicin
Strength 3 mg/ml + 1 mg/ml
Pharmaceutical form Eye drops
Clear, colourless or slightly yellow solution.
pH: 6.7 - 7.7
Osmolality: 0.270 – 0.330 Osmol/kg
How is it taken Ocular
Excipients Sodium citrate,, Monobasic sodium phosphate monohydrate,, Disodium phosphate dodecahydrate,, Purified water.
Is it available? No, it is listed as not available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 2 years.
The product does not contain preservatives.
Shelf-life after first opening: After administration the single-dose container should be discarded even if only partially used.
Storage Store below 30°C.
Store the single-dose containers in the sachet in order to protect from light and moisture.
For storage conditions after first opening of the medicinal product, see section 6.3.
Drug group (ATC) Anti-inflammatory agents and anti-infectives in combination, corticosteroids and anti-infectives in combination
  1. S Sensory organ drugs
    1. S01 Ophthalmologicals
      1. S01C Antiinflammatory agents and antiinfectives in combination
        1. S01CA Corticosteroids and antiinfectives in combination, opthalmologic
          1. S01CA01 dexamethasone and antiinfectives
Marketing authorisation PLGB 53941/0018 (first authorised 8 November 2024)
Marketing authorisation holder SIFI Pharmaceuticals Limited
Codes BNF 11040100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.